Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(17%)

Phase Distribution

Ph early_phase_1
1
17%
Ph phase_2
2
33%
Ph phase_4
3
50%

Phase Distribution

1

Early Stage

2

Mid Stage

3

Late Stage

Phase Distribution6 total trials
Early Phase 1First-in-human
1(16.7%)
Phase 2Efficacy & side effects
2(33.3%)
Phase 4Post-market surveillance
3(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

60.0%

3 of 5 finished

Non-Completion Rate

40.0%

2 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Completed(3)
Terminated(2)
Other(1)

Detailed Status

Completed3
Withdrawn1
unknown1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
75.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (16.7%)
Phase 22 (33.3%)
Phase 43 (50.0%)

Trials by Status

completed350%
withdrawn117%
unknown117%
terminated117%

Recent Activity

0 active trials
Showing 5 of 6
withdrawnphase_4

In Hospital IM Naltrexone: A Pilot Study

NCT05087771
unknownphase_2

Medication Maintenance Therapy in Community Pharmacy Settings

NCT04139213
completedphase_2

Opioid Relapse & HIV Risk: 48 Versus 24 Weeks of Injectable Extended Release Naltrexone

NCT01882361
completedearly_phase_1

Medication Maintenance Therapy in Community Pharmacy Settings

NCT03766893
terminatedphase_4

Long-Acting Injectable Naltrexone Treatment of Alcohol Dependence in Primary Care vs. in Specialized Chemical Dependence Treatment: A Pilot Trial

NCT00461890
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT05087771Phase 4

In Hospital IM Naltrexone: A Pilot Study

Withdrawn
NCT04139213Phase 2

Medication Maintenance Therapy in Community Pharmacy Settings

Unknown
NCT01882361Phase 2

Opioid Relapse & HIV Risk: 48 Versus 24 Weeks of Injectable Extended Release Naltrexone

Completed
NCT03766893Early Phase 1

Medication Maintenance Therapy in Community Pharmacy Settings

Completed
NCT00461890Phase 4

Long-Acting Injectable Naltrexone Treatment of Alcohol Dependence in Primary Care vs. in Specialized Chemical Dependence Treatment: A Pilot Trial

Terminated
NCT00453804Phase 4

Injectable Versus Oral Naltrexone Treatment of Alcohol Dependence In Serious Mental Illness (SMI)

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6